₹1,494.30
+₹45.70 (+3.15%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹2,477 Cr
P/E
56.51
ROE
11.73%
ROCE
17.24%
About Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals in its Endeavour to move ahead has now ventured into manufacturing of dietary /herbal supplements, nutraceuticals, and other healthcare products along with Animal Healthcare products also with products ranging from allopathic formulations to on field diagnostic kits, Company’s main aim is to be a holistic healthcare provider.
Founded
1987
CEO
Daulat N Medhora
Employees
736
HQ
Mumbai, Maharashtra
About Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals in its Endeavour to move ahead has now ventured into manufacturing of dietary /herbal supplements, nutraceuticals, and other healthcare products along with Animal Healthcare products also with products ranging from allopathic formulations to on field diagnostic kits, Company’s main aim is to be a holistic healthcare provider.
Founded:1987
CEO:Daulat N Medhora
Employees:736
HQ:Mumbai, Maharashtra
Finished Products
1Sales
₹1,431.61Cr2Other Operating Income
₹5.83CrRaw Materials
1Raw Materials consumed
₹1,085.07CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,590
52W Low
₹1,400
Volume33.11K
Avg VolumeN/A
Beta0.48
Dividend Yield0.02%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
56.51x
Valuation
P/B Ratio
9.20x
Valuation
EPS
₹26.50
Valuation
Dividend Yield
0.02%
Valuation
ROE
11.73%
Profitability
ROCE
17.24%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
83.1%
International
16.9%
Domestic83.1%
Export16.9%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.80x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
22.2%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.